ymjЯкутский медицинский журналYakut Medical Journal1813-19052312-1017ЯНЦ КМП10.25789/YMJ.2023.84.23ymj-358Research ArticleАКТУАЛЬНАЯ ТЕМАACTUAL TOPICРаспространенность социальных факторов риска и ее тенденции в популяции женщин репродуктивного возраста на территориальном уровнеPrevalence of social risk factors and its trends in the population of women of reproductive age at the territorial levelАминодоваИ. П.AminodovaI. P.

Аминодова  Изабелла Петровна – к.м.н., н.с. ; доцент  

Москва

 Aminodova Izabella P. – PhD, leading researcher, Department of Lifestyle and Population Health Protection;  Assistant Professor, Department of Obstetrics and Gynecology, Faculty of Postgraduate Education; research fellow

aminodovsi@mail.ruhttps://orcid.org/0000-0003-4831-1783ВасильеваТ. П.VasilievaT. P.

Васильева Татьяна Павловна – д.м.н., проф. 

Москва

Vasilieva Tatyana P. – MD, Professor of the Department of Lifestyle and Population Health Protection 

vasileva_tp@mail.ruhttps://orcid.org/0000-0002-3292-1424РусскихС. В.RusskikhS. V.

Русских Сергей Валерьевич – к.м.н., в.н.с.; приглаш. препод. 

Москва

Russkikh Sergey V. – PhD, leading researcher, Department of Lifestyle and Public Health Protection; visiting lecturer, Faculty of Social Sciences, Department of Policy and Management 

russkikh1@mail.ruhttps://orcid.org/0000-0003-2592-5125АфанасьеваЛ. Н.AfanasyevaL. N.

Афанасьева Лена Николаевна – к.м.н., доцент

Afanasyeva  Lena N. – Candidate of Medical Sciences, Associate Professor

lenanik2007@mail.ruhttps://orcid.org/0000-0003-1646-7345ВасильевМ. Д.VasilievM. D.

Васильев Михаил Дмитриевич – к.м.н., н.с.  

Vasiliev Mikhail D. – PhD, researcher, Department of Lifestyle Studies and Population Health Protection 

vasilev.m.d@yandex.ruНац. НИИ общ. здоровья им. Н.А. Семашко; Ивановский ГМУРоссияFederal State Budgetary Scientific Institution N.A. Semashko National Research Institute of Public Health; ‘Belaya Roza’ Medical Center Ivanovo; Ivanovo State Medical UniversityRussian FederationНац. НИИ общ. здоровья им. Н.А. СемашкоРоссияSemashko National Research Institute of Public HealthRussian FederationНац. НИИ общ. здоровья им. Н.А. Семашко; Нац. иссл. ун-т «Высшая школа экономики»РоссияFederal State Budgetary Scientific Institution N.A. Semashko National Research Institute of Public Health; National Research University Higher School of EconomicsRussian FederationСВФУ им. М.К. АммосоваРоссияM.K. Ammosov North-Eastern Federal UniversityRussian FederationНац. НИИ им. Н.А. СемашкоРоссияFederal State Budgetary Institution N.A. Semashko National Research Institute of Public HealthRussian Federation2023110220250494100Copyright © Аминодова И.П., Васильева Т.П., Русских С.В., Афанасьева Л.Н., Васильев М.Д., 20252025Аминодова И.П., Васильева Т.П., Русских С.В., Афанасьева Л.Н., Васильев М.Д.Aminodova I.P., Vasilieva T.P., Russkikh S.V., Afanasyeva L.N., Vasiliev M.D.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://ymj.elpub.ru/jour/article/view/358

Проведенное авторами исследование направлено на получение на территориальном уровне новых теоретических данных о рисках злокачественных новообразований женской половой системы, связанных с разным соотношением факторов риска. На первом этапе исследования осуществлен сбор информации о факторах риска возникновения онкологических злокачественных заболеваний из отечественных и зарубежных источников литературы. На втором этапе получены данные о частоте факторов онкориска, входящих в группу «Социально-гигиенические факторы», за 1995-2020 гг.

Полученные данные подтверждают взаимосвязь социально-гигиенических факторов риска с показателями заболеваемости злокачественными заболеваниями органов репродуктивной системы у женщин и позволяют рекомендовать к включению в комплекс показателей для оценки рисковой отягощенности территории такие факторы риска, как курение матери, поздняя первая беременность и возраст беременной старше 40 лет, раннее начало половой жизни, большое число половых партнеров.

Introduction. Tumours affecting the reproductive organs are diagnosed in women of fertile age in 20–40% of cases. Therefore, the current situation not only affects the quality and life expectancy of patients, but also leads to a decrease in the reproductive potential of the country. Relevance of Research. The authors’ research aims to obtain new theoretical data regarding the risks of malignant neoplasms in the female genital system correlated with various ratios of risk factors at the territorial level. Materials and Methods. During the initial research stage, the authors employed the analytical method to gather data on risk factors for oncological malignancies identified through content analysis of both domestic and foreign literature sources. During the second research stage, data were collected regarding the incidence of cancer risk factors classified as social and hygienic factors. The data were collected retrospectively for the period of 1995–2020 (n = 36935). The data processing programme comprised the calculation of the prevalence rate of the risk of malignant neoplasms of the reproductive system in women of reproductive age. Research methodical specifics involved constructing parallel chronograms of each cancer risk factor and new onsets of malignant cancer diseases broken down by years of the research period. These data were used as evidence of effectiveness of cancer risk management procedures within the territory. Conclusion. The data obtained bolster the correlation between malignant reproductive diseases in women and social and hygienic risk factors. This substantiates the suggestion to incorporate such risk factors as maternal smoking, late first pregnancy and maternal age over 40 years, early sexual activity and large number of sexual partners in the set of indicators for assessing the risk burden in the territory

общественное здоровьесоциальные факторы рискасоциальная детерминантасистемный подходрепродуктивный возрастзлокачественными заболеваниями органов репродуктивной системы у женщинрисках злокачественных новообразований женской половой системыpublic healthsocial risk factorssocial determinantsystemic approachreproductive agemalignant diseases of reproductive system organs in womenrisks of malignant neoplasms of female genital systemReferencesАминодова И.П., Лапочкина Н.П. Комплексная терапия и реабилитация пациенток с сочетанной патологией молочных желез и дисплазией шейки матки // Опухоли женской репродуктивной системы. 2014;(4):68-70 doi: https://doi.org/10.17650/1994-4098-2014-0-4-68-70Aminodova I.P., Lapochkina N.P. Complex therapy and rehabilitation of patients with combined pathology of mammary glands and cervical dysplasia. Tumors of the female reproductive system. 2014;(4):68-70 doi: https://doi.org/10.17650/1994-4098-2014-0-4-68-70Бурчаков Д.В. Новые и модифицируемые факторы риска заболеваний молочной железы // Эффективная фармакотерапия. Акушерство и гинекология. 2017; 2:22-27Burchakov D.V. New and modifiable risk factors of breast diseases. Effective pharmacotherapy. Obstetrics and Gynecology. 2017; 2:22-27Волобуев А.И. Результаты обследования женщин с сочетанными доброкачественными гиперпластическими процессами молочных желез и половых органов //Акуш. и гинек. 2003. № 5. С. 27.Volobuev, A.I. Results of examination of women with combined benign hyperplastic processes of mammary glands and genital organs / A.I. Volobuev //Akush. i gynec. - 2003. – No. 5. - P. 27.Дикке Г.Б. Современные подходы к вторичной профилактике рака шейки матки АиГ 2018 №4 131-13.doi: https://dx.doi.org/10.18565/aig.2018.4.131-137Dicke G.B. Modern approaches to secondary prevention of cervical cancer AiG 2018 No. 4 131-13.doi: https://dx.doi.org/10.18565/aig.2018.4.131-137Добренький М.Н., Добренькая Е.М. Факторы риска, современные возможности профилактики и ранней диагностики рака молочной железы // Фундаментальные исследования. 2008. № 8. С. 107–108.Dobrenkyi M.N., Dobren'kaya E.M. Risk factors, modern possibilities of prevention and early diagnosis of breast cancer // Fundamental Research. - 2008. – No. 8. - P. 107-108.Дыхно Ю.А., Черненко О.Н. Анализ факторов риска рака молочной железы у женщин республики Хакасия // Сибирский онкологический журнал. 2012. № 6 (54). С. 47–51.Dykhno Yu.A., Chernenko O.N. Analysis of breast cancer risk factors in women of the Republic of Khakassia // Siberian Oncological Journal. 2012. No. 6 (54). P. 47-51.Качалина Т.С. Онкориски эндометриоза // Ремедиум Приволжье. 2017. № 3. С. 21.Kachalina T. S. Oncorrhizae of endometriosis. // Remedium Privolzhye. - 2017. – No. 3. - P. 21Коваленко И.М., Берштейн Л.М. Сахарный диабет как модификатор течения опухолей женской репродуктивной сферы // Вопр. онкол. 2014. Т. 60(1). С. 25-31.Kovalenko I.M. Berstein L.M. Diabetes mellitus as a modifier of the course of tumors of the female reproductive sphere // Vopr.Onkol. 2014. Т. 60(1). P. 25-31.Конфаундинг-факторы папилломавирусной инфекции и цервикальной дисплазии у молодых женщин / Т.Е. Белокриницкая др.] // Доктор.ру 2015;14(115): 7-12Belokrinitskaya T.E., Frolova I.I., Tarbaeva D.A., Glotova E.Y., Zolotaryova A.A., Maltseva T.V. Confounding factors of papillomavirus infection and cervical dysplasia in young women. Doctor.ru 2015;14(115): 7-12Роль гормональных нарушений в канцерогенезе опухолей женской репродуктивной системы / Н.А. Бабаева [и др.] // Акушерство и гинекология. Онкогинекология. 2017. №1. С.76-82.Babaeva N.A., Ashrafyan L.A., Antonova I.B., Aleshikova O.I., Ivashina S.V. Role of hormonal disorders in carcinogenesis of tumors of the female reproductive system. Obstetrics and Gynecology. Oncogynecology. No. 1. 2017. P.76-82.Плоскоклеточные интраэпителиальные поражения шейки матки: возможности ранней диагностики и тактики ведения пациенток / Г.Р. Байрамова [и др.] // Доктор.Ру. 2019. № 11 (166). С. 61–67. DOI: 10.31550/1727-2378-2019-166-11-61-67.Bayramova G.R., Baranov I.I., Ezhova L.S., Trofimov D.Yu., Priputnevich T.V., Amirkhanyan A.S., Starinskaya A.M. Squamous cell intraepithelial lesions of the cervix: opportunities for early diagnosis and management tactics for patients // Doctor.Ru. 2019. No. 11 (166). P. 61-67. DOI: 10.31550/1727-2378-2019-166-11-61-67Патогенетическое лечение неопластических процессов шейки матки: новые подходы / Т.Н. Бебнева [и др.] // Доктор.Ру. 2016 3(120): 9–14.Bebneva T.N., Muizhnek E.L., Rogovskaya S.I., Kiselev V.I., Ashrafyan L.I.I., Kiselev V.I.I., Ashrafyan L.A. Pathogenetic treatment of neoplastic processes of the cervix: new approaches. Doctor.ru. 2016; 3(120): 9-14.Эпидемиология рака в мире / Э.К. Макимбетов [и др.] // Современные проблемы науки и образования. 2020. № 2. С.168. doi: 10.17513/spno.29718Makimbetov E.K., Salihar R.I., Tumanbaev A.M., Toktanalieva A.N., Kerimov A.D. Epidemiology of cancer in the world // Modern Problems of Science and Education. 2020. – No. 2. - P.168. doi: 10.17513/spno.29718Максимов С.Я., Гусейнов К.Д., Косников А.Г. Факторы риска возникновения злокачественных новообразований органов репродуктивной системы женщин. Вопросы онкологии. 2003. Т. 49 (4): 496–501.Maksimov S.Y., Huseynov K.D., Kosnikov A.G. Risk factors of malignant neoplasms of reproductive system organs of women. Voprosy Onkologii. 2003; 49 (4): 496-501.Практические рекомендации по лекарственному лечению рака тела матки и сарком матки / В.М. Нечушкина [и др.] // Злокачественные опухоли: Практические рекомендации RUSSCO #3s2, 2022 (том 12). 260–275. doi: 10.18027/2224-5057-2021-11-3s2-14Practical recommendations on drug treatment of uterine corpus cancer and uterine sarcomas / Nechushkina V.M. [et al.]. Malignant tumors: RUSSCO Practical Recommendations #3s2, 2022 (vol. 12). 260–275. doi: 10.18027/2224-5057-2021-11-3s2-14Рак молочной железы и программа экстракорпорального оплодотворения / А.А. Пароконная [и др.] // Опухоли женской репродуктивной системы. 2008. №4.doi: https://doi.org/10.17650/1994-4098-2008-0-4-52-56Parokonnaya A. A., Nechushkin M. I., Kampova-Polevaya E. B., Lyubchenko L. N. Breast cancer and the program of in vitro fertilization // Tumors of the female reproductive system. 2008. No. 4.doi: https://doi.org/10.17650/1994-4098-2008-0-4-52-56Рак репродуктивных органов: эпидемиология, факторы риска / Л.Ф. Писарева [и др.] // Сибирский онкологический журнал. 2003. №1. С. 56-71Pisareva L.F., Melnik A.A., Odintsova I.N., Martynova N.A. Cancer of reproductive organs: epidemiology, risk factors // Siberian Oncological Journal. 2003. No.1. P.56-71Состояние онкологической помощи населению России в 2020 году / Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2021. илл. 239 с.The state of oncologic aid to the Russian population in 2020. Under the editorship of A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova - M.: P.A. Herzen MNIOI - branch of FGBU "NMRC Radiology" of the Ministry of Health of Russia, 2021. - Ill. - 239 с.Состояние онкологической помощи населению России в 2021 году / Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022. илл. 239 с.The state of oncologic aid to the Russian population in 2021. Under the editorship of A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova - M.: P.A. Herzen MNIOI - branch of FGBU "NMRC Radiology" of the Ministry of Health of Russia, 2022. - Ill. - 239 p.Эпидемиология и скрининг рака молочной железы / В.Ф. Семиглазов [и др.] // Вопросы онкологии. 2017; 3(63): 375-384.doi: https://doi.org/10.37469/0507-3758-2017-63-3-375-384Epidemiology and screening of breast cancer / Semiglazov V.F [et al.] // Issues in Oncology. 2017; 3(63): 375-384.doi: https://doi.org/10.37469/0507-3758-2017-63-3-375-384Althuis M.D. Breast cancers among very young premenopausal women (United States) / Althuis M.D., Brogan D.D., Coates R.J., Daling J.R., Gammon M.D., Malone K.E., et al. // Cancer Causes Control. 2003:151–60. doi: 10.1023/a:1023006000760Althuis M.D. Breast cancers among very young premenopausal women (United States) / Althuis M.D., Brogan D.D., Coates R.J., Daling J.R., Gammon M.D., Malone K.E., et al. // Cancer Causes Control. 2003:151–60. doi: 10.1023/a:1023006000760Alvarado-Cabrero I., Rodríguez-Gómez A., Castelan-Pedraza J., Valencia-Cedillo R. Metastatic ovarian tumors: a clinicopathologic study of 150 cases. Anal Quant Cytopathol Histpathol 2013 Oct;35(5):241–8. DOI: 10.1109/chicc.2006.4347343. PMID: 24282903Alvarado-Cabrero I., Rodríguez-Gómez A., Castelan-Pedraza J., Valencia-Cedillo R. Metastatic ovarian tumors: a clinicopathologic study of 150 cases. Anal Quant Cytopathol Histpathol 2013 Oct;35(5):241–8. DOI: 10.1109/chicc.2006.4347343. PMID: 24282903Andersen ZJ, Jørgensen JT, Grøn R, Brauner EV, Lynge E. Active smoking and risk of breast cancer in a Danish nurse cohort study. // BMC Cancer. 2017 Aug 22;17(1):556. doi: 10.1186/s12885-017-3546-4.Andersen ZJ, Jørgensen JT, Grøn R, Brauner EV, Lynge E. Active smoking and risk of breast cancer in a Danish nurse cohort study. // BMC Cancer. 2017 Aug 22;17(1):556. doi: 10.1186/s12885-017-3546-4.Carey L. A. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study Carey, L. A., Perou, C. M., Livasy, C. A.. 2006; 295 (21): 2492-2502. doi: 10.1001/jama.295.21.2492.Carey L. A. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study Carey, L. A., Perou, C. M., Livasy, C. A.. 2006; 295 (21): 2492-2502. doi: 10.1001/jama.295.21.2492.Chen Y., Liu L., Zhou Q. Body mass index had different effects on premenopausal and postmenopausal breast cancer risks: a dose-response metaanalysis with 3 318 796 subjects from 31 cohort studies. BMC Public Health 2017;17(1):936–47. PMID: 29216920. DOI: 10.1186/s12889-017-4953-9.Chen Y., Liu L., Zhou Q. Body mass index had different effects on premenopausal and postmenopausal breast cancer risks: a dose-response metaanalysis with 3 318 796 subjects from 31 cohort studies. BMC Public Health 2017;17(1):936–47. PMID: 29216920. DOI: 10.1186/s12889-017-4953-9.Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118,964 women with breast cancer from 117 epidemiological studies. Lancet Oncol. 2012; 13 (11): 1141-1151. doi: 10.1016/S1470-2045(12)70425-4Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118,964 women with breast cancer from 117 epidemiological studies. Lancet Oncol. 2012; 13 (11): 1141-1151. doi: 10.1016/S1470-2045(12)70425-4Committee on Gynecologic Practice, American College of Obstetricians and Gynecologists. ACOG committee opinion. Induced abortion and breast cancer risk. Number 285, August 2003. Int J Gynaecol Obstet. 2003; 83(2):233-5. doi: 10.1016/s0020-7292(03)00411-9. PMID: 14631935.Committee on Gynecologic Practice, American College of Obstetricians and Gynecologists. ACOG committee opinion. Induced abortion and breast cancer risk. Number 285, August 2003. Int J Gynaecol Obstet. 2003; 83(2):233-5. doi: 10.1016/s0020-7292(03)00411-9. PMID: 14631935.Fang H.F., Miao N.F., Chen C.D., Sithole T., Chung M. Risk of cancer in patients with insomnia, parasomnia, and obstructive sleep apnea: a nationwide nested case-control study // J. Cancer. 2015; 6 (1): 1140–1147. doi: 10.7150/jca.12490Fang H.F., Miao N.F., Chen C.D., Sithole T., Chung M. Risk of cancer in patients with insomnia, parasomnia, and obstructive sleep apnea: a nationwide nested case-control study // J. Cancer. 2015; 6 (1): 1140–1147. doi: 10.7150/jca.12490Guerriero S., Alcazar J.L., Pascual M.A. Preoperative diagnosis of metastatic ovarian cancer is related to origin of primary tumor. Ultrasound Obstet Gynecol 2012;39(5):581–6. DOI: 10.1002/uog.10120. PMID: 21998039Guerriero S., Alcazar J.L., Pascual M.A. Preoperative diagnosis of metastatic ovarian cancer is related to origin of primary tumor. Ultrasound Obstet Gynecol 2012;39(5):581–6. DOI: 10.1002/uog.10120. PMID: 21998039Hamajima N., Hirose K., Tajima K. et al. Alcohol, tobacco and breast cancer – collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women with out the disease // Br. J. Cancer. 2002; 87:1234-1245. doi: 10.1038/sj.bjc.6600596Hamajima N., Hirose K., Tajima K. et al. Alcohol, tobacco and breast cancer – collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women with out the disease // Br. J. Cancer. 2002; 87:1234-1245. doi: 10.1038/sj.bjc.6600596Islam T., Matsuo K., Ito H. Reproductive and hormonal risk factors for luminal, HER2-overexpressing, and triple-negative breast cancer in Japanese women // Ann. Oncol. 2012; 23 (9): 2435-2441. doi: 10.1093/annonc/mdr613.Islam T., Matsuo K., Ito H. Reproductive and hormonal risk factors for luminal, HER2-overexpressing, and triple-negative breast cancer in Japanese women // Ann. Oncol. 2012; 23 (9): 2435-2441. doi: 10.1093/annonc/mdr613.Lacey J.V. Jr., Kreimer A.R., Buys S.S. Breast cancer epidemiology according to recognized breast cancer risk factors in Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort // BMC Cancer. 2009; 9:84. doi: 10.1186/1471-2407-9-84Lacey J.V. Jr., Kreimer A.R., Buys S.S. Breast cancer epidemiology according to recognized breast cancer risk factors in Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort // BMC Cancer. 2009; 9:84. doi: 10.1186/1471-2407-9-84Pappo I., Lerner-Geva L., Halevy A., Olmer L., Friedel S., Raziel A., Schachter M., RonEl R. The Possible Association between IVF and Breast Cancer Incidence. Ann Surg Oncol 2008;15(4):1048—55. doi: 10.1245/s10434-007-9800-2Pappo I., Lerner-Geva L., Halevy A., Olmer L., Friedel S., Raziel A., Schachter M., RonEl R. The Possible Association between IVF and Breast Cancer Incidence. Ann Surg Oncol 2008;15(4):1048—55. doi: 10.1245/s10434-007-9800-2Patterson R. E. Medical comorbidities predict mortality in women with a history of early stage breast cancer [Breast cancer research and treatment] / Patterson, R. E., Flatt, S. W., Saquib, N. 2010;122 (3): 859-865. doi: 10.1007/s10549-010-0732-3Patterson R. E. Medical comorbidities predict mortality in women with a history of early stage breast cancer [Breast cancer research and treatment] / Patterson, R. E., Flatt, S. W., Saquib, N. 2010;122 (3): 859-865. doi: 10.1007/s10549-010-0732-3Singlebaru K.W., Gapstur S.M. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA 2001;286(17): 2143—51. 14.Singlebaru K.W., Gapstur S.M. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA 2001;286(17): 2143—51. 14.Sternfeld B. Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study [Cancer Epidemiology and Prevention Biomarkers] / Sternfeld, B., Weltzien, E., Quesenberry, C. P. 2009; 18 (1): 87- 95. doi: 10.1158/1055-9965.EPI-08-0595Sternfeld B. Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study [Cancer Epidemiology and Prevention Biomarkers] / Sternfeld, B., Weltzien, E., Quesenberry, C. P. 2009; 18 (1): 87- 95. doi: 10.1158/1055-9965.EPI-08-0595Vachon C., Cerhan J.R., Vierkant R.A., Sellers T.A. Investigation of an interaction of alcohol intake and family history on breast cancer risk in the Minnesota Breast Cancer Family Study. Cancer 2001;92(2): 240—8. doi: 10.1002/10970142(20010715)92:2<240::aid-cncr1315>3.0.co;2-iVachon C., Cerhan J.R., Vierkant R.A., Sellers T.A. Investigation of an interaction of alcohol intake and family history on breast cancer risk in the Minnesota Breast Cancer Family Study. Cancer 2001;92(2): 240—8. doi: 10.1002/10970142(20010715)92:2<240::aid-cncr1315>3.0.co;2-iWalker S, Hamilton W. Risk of cervical cancer in symptomatic women aged ≥40 in primary care: A case-control study using electronic records. Eur J Cancer Care (Engl). 2017. doi: 10.1111/ecc.12706Walker S, Hamilton W. Risk of cervical cancer in symptomatic women aged ≥40 in primary care: A case-control study using electronic records. Eur J Cancer Care (Engl). 2017. doi: 10.1111/ecc.12706Yada-Hashimoto N., Yamamoto T., Kamiura S. Metastatic ovarian tumors: a review of 64 cases. Gynecol Oncol 2013;89(2):314–7. DOI: 10.1016/s0090–8258(03)00075–1. PMID: 12713997Yada-Hashimoto N., Yamamoto T., Kamiura S. Metastatic ovarian tumors: a review of 64 cases. Gynecol Oncol 2013;89(2):314–7. DOI: 10.1016/s0090–8258(03)00075–1. PMID: 127139973Yu H.C., Lin C.Y., Chang W.C. et al. Increased association between endometriosis and endometrial cancer: a nationwide population-based retrospective cohort study / / Int. J. Gynecol. Cancer. 2015; 25 (3): 447-452. doi: 10.1097/IGC.00000000000003843Yu H.C., Lin C.Y., Chang W.C. et al. Increased association between endometriosis and endometrial cancer: a nationwide population-based retrospective cohort study / / Int. J. Gynecol. Cancer. 2015; 25 (3): 447-452. doi: 10.1097/IGC.0000000000000384

The authors declare that there are no conflicts of interest present.